1. Home
  2. AROW vs RLAY Comparison

AROW vs RLAY Comparison

Compare AROW & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AROW
  • RLAY
  • Stock Information
  • Founded
  • AROW 1851
  • RLAY 2015
  • Country
  • AROW United States
  • RLAY United States
  • Employees
  • AROW N/A
  • RLAY N/A
  • Industry
  • AROW Major Banks
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AROW Finance
  • RLAY Health Care
  • Exchange
  • AROW Nasdaq
  • RLAY Nasdaq
  • Market Cap
  • AROW 418.8M
  • RLAY 490.3M
  • IPO Year
  • AROW N/A
  • RLAY 2020
  • Fundamental
  • Price
  • AROW $25.06
  • RLAY $3.23
  • Analyst Decision
  • AROW Hold
  • RLAY Strong Buy
  • Analyst Count
  • AROW 1
  • RLAY 11
  • Target Price
  • AROW $28.00
  • RLAY $18.40
  • AVG Volume (30 Days)
  • AROW 42.3K
  • RLAY 1.8M
  • Earning Date
  • AROW 07-24-2025
  • RLAY 05-05-2025
  • Dividend Yield
  • AROW 4.44%
  • RLAY N/A
  • EPS Growth
  • AROW N/A
  • RLAY N/A
  • EPS
  • AROW 1.70
  • RLAY N/A
  • Revenue
  • AROW $135,107,000.00
  • RLAY $7,679,000.00
  • Revenue This Year
  • AROW $23.54
  • RLAY $14.58
  • Revenue Next Year
  • AROW $7.07
  • RLAY N/A
  • P/E Ratio
  • AROW $15.02
  • RLAY N/A
  • Revenue Growth
  • AROW 3.10
  • RLAY N/A
  • 52 Week Low
  • AROW $22.72
  • RLAY $1.78
  • 52 Week High
  • AROW $34.63
  • RLAY $10.72
  • Technical
  • Relative Strength Index (RSI)
  • AROW 42.15
  • RLAY 58.16
  • Support Level
  • AROW $25.44
  • RLAY $2.75
  • Resistance Level
  • AROW $26.54
  • RLAY $3.39
  • Average True Range (ATR)
  • AROW 0.50
  • RLAY 0.20
  • MACD
  • AROW -0.15
  • RLAY 0.04
  • Stochastic Oscillator
  • AROW 0.00
  • RLAY 77.78

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: